UNLABELLED: Liberal versus restrictive red blood cell (RBC) transfusion triggers have been debated for years. This review illustrates the human body's physiologic response to acute anemia and summarizes the evidence from prospective randomized trials (RCTs) for restrictive use of RBC transfusions in high-risk patients. During progressive anemia, the human body maintains the oxygen delivery to the tissues by an increase in cardiac output and peripheral oxygen extraction. Seven RCTs with a total of 5,566 high-risk patients compared a restrictive hemoglobin (Hb) transfusion trigger (Hb < 70 or < 80 g/l) with a liberal Hb transfusion trigger (Hb < 90 or < 100 g/l). Unanimously these studies show non-inferiority, safety, and a significant reduction in RBC transfusions in the restrictive groups. In one RCT mortality was higher in the liberal Hb transfusion group, and in two additional RCTs mortality of subgroups or after risk adjustment was significantly higher in the liberal Hb transfusion trigger groups. CONCLUSION: Strong RCT evidence suggests the safety of restrictive transfusion triggers. As a consequence, an Hb transfusion trigger of <70 g/l is recommended for high risk patients.
UNLABELLED: Liberal versus restrictive red blood cell (RBC) transfusion triggers have been debated for years. This review illustrates the human body's physiologic response to acute anemia and summarizes the evidence from prospective randomized trials (RCTs) for restrictive use of RBC transfusions in high-risk patients. During progressive anemia, the human body maintains the oxygen delivery to the tissues by an increase in cardiac output and peripheral oxygen extraction. Seven RCTs with a total of 5,566 high-risk patients compared a restrictive hemoglobin (Hb) transfusion trigger (Hb < 70 or < 80 g/l) with a liberal Hb transfusion trigger (Hb < 90 or < 100 g/l). Unanimously these studies show non-inferiority, safety, and a significant reduction in RBC transfusions in the restrictive groups. In one RCT mortality was higher in the liberal Hb transfusion group, and in two additional RCTs mortality of subgroups or after risk adjustment was significantly higher in the liberal Hb transfusion trigger groups. CONCLUSION: Strong RCT evidence suggests the safety of restrictive transfusion triggers. As a consequence, an Hb transfusion trigger of <70 g/l is recommended for high risk patients.
Authors: Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner Journal: N Engl J Med Date: 2011-12-14 Impact factor: 91.245
Authors: Wen-Chih Wu; Tracy S Smith; William G Henderson; Charles B Eaton; Roy M Poses; Georgette Uttley; Vincent Mor; Satish C Sharma; Michael Vezeridis; Shukri F Khuri; Peter D Friedmann Journal: Ann Surg Date: 2010-07 Impact factor: 12.969
Authors: Aryeh Shander; Axel Hofmann; Sherri Ozawa; Oliver M Theusinger; Hans Gombotz; Donat R Spahn Journal: Transfusion Date: 2009-12-09 Impact factor: 3.157
Authors: Patrick Lauscher; Harry Kertscho; Olga Schmidt; René Zimmermann; Peter Rosenberger; Kai Zacharowski; Jens Meier Journal: Crit Care Med Date: 2013-04 Impact factor: 7.598
Authors: Timothy S Walsh; Julia A Boyd; Douglas Watson; David Hope; Steff Lewis; Ashma Krishan; John F Forbes; Pamela Ramsay; Rupert Pearse; Charles Wallis; Christopher Cairns; Stephen Cole; Duncan Wyncoll Journal: Crit Care Med Date: 2013-10 Impact factor: 7.598
Authors: Lorenz Peterer; Christian Ossendorf; Kai Oliver Jensen; Georg Osterhoff; Ladislav Mica; Burkhardt Seifert; Clément M L Werner; Hans-Peter Simmen; Hans-Christoph Pape; Kai Sprengel Journal: BMC Geriatr Date: 2019-12-19 Impact factor: 3.921
Authors: Y Kalbas; M Lempert; F Ziegenhain; J Scherer; V Neuhaus; R Lefering; M Teuben; K Sprengel; H C Pape; Kai Oliver Jensen Journal: Eur Geriatr Med Date: 2021-07-29 Impact factor: 1.710